- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05226195
Effect of Kinesio® Taping in Total Knee Replacement Surgery
The Effect of Kinesio® Taping on Post-Surgical Functional Outcomes in Patients Undergoing Total Knee Replacement Surgery
Total knee replacement, which is the gold standard surgical treatment method applied in today's conditions, in order to maintain the patient's daily life without pain, to provide the knee joint range of motion, to eliminate the deformity and instability in the knee joint in advanced stage (Stage 3-4) knee osteoarthritis (OA) that does not benefit from conservative treatment. Obtaining the best clinical outcome for the patient after surgery is only possible with the implementation of post-surgical physical therapy and rehabilitation programs.
Edema and pain occurring in the early post-surgical period prevent patients from moving freely, and as a result, the psychological state of the patients is also affected. With effective physiotherapy, besides relieving pain and edema, patients' sensorimotor performances, proprioceptive senses and body balances are restored, and thus the brain is taught how to maintain joint functions. For this reason, new physiotherapy methods are being developed every day for this purpose.
"Kinesio Taping" (KT) is one of the modern physiotherapy methods that has been widely used in sports orthopedics in recent years. It was developed by Kenzo Kase in 1973 and is used clinically to relieve pain and edema, and to increase motor function in musculoskeletal diseases. In this method, an adhesive cotton-based tape called kinesio tape is used. The elastic structure of this band, which allows it to extend 130-140% of its original length, similar to the skin, together with its three-dimensional "fingerprint" texture specific to the band, causes the formation of microfolds on the skin. The formation of these folds; It is known that it increases the proprioceptive perception of the related joint by stimulating skin mechanoreceptors. It also reduces the pressure under the skin and helps relieve pain by increasing lymphatic drainage. The Epidermis-Dermis-Fascia (EDF) taping method is a KB method that has been developed in recent years. It provides less tension and is more easily applied to painful areas. The narrow strips of the applied tape provide more stimulation in the most superficial tissues5. Although studies on the effect of other application methods on rehabilitation after knee replacement surgery are available in the literature, there is no study in the literature showing the effects of the EDF technique.
In this study, it is aimed to evaluate the effect of KT applied with EDF technique on clinical results in the early postoperative period in patients who have undergone total knee replacement surgery. The hypothesis of this study is; It was determined that "pain and edema decrease and functional gain increases in patients who underwent KT after total knee prosthesis surgery".
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06810
- Baskent University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- to be volunteered to participate in the study.
- It will be performed in patients who have stage 3-4 osteoarthritis according to the "Kellgren-Lawrence" classification and therefore undergo total knee replacement surgery in a ligament-cutting design in the Department of Orthopedics and Traumatology of Baskent University Ankara Hospital.
Exclusion Criteria:
- Patients who underwent total knee prosthesis surgery in a hinge-preserving and hinged design
- Patients who underwent simultaneous bilateral total knee prosthesis surgery
- Patients with lymphedema
- Skin lesions at the place where the taping will be applied
- Local sensitivity in the skin sensitivity test to be performed the day before the application
- Chronic kidney failure patients
- Patients with congestive heart failure
- Patients with a body mass index of 30 and above
- Patients who underwent surgery for pathological fractures
- Patients who underwent total knee replacement revision surgery
- Patients who had previously undergone high tibial osteotomy or unicondylar knee replacement surgery
- Patients who underwent surgery due to traumatic arthrosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1: Sterile Kinesio tape application
The standard post-surgical protocol and sterile EDF kinesio-taping will be applied to this group.
The clinical evaluation will be made on the 15th, 45th and 90th days; functional measurements will be taken.
The follow-up period was determined as 3 months.
|
The standard post-surgical protocol and sterile EDF kinesio-taping will be applied to this group in the operating room at the end of the surgery in a sterile manner according to the epidermis-dermis-fascia (EDF) technique previously described in the literature (without tension).
Original KinesioTex® Tape will be used in the study.
The day of taping will be considered as Day 0 and the tapes will be changed on the 4th day, the 7th day.
|
|
No Intervention: Group 2: Control group
The standard post-surgical protocol applied in our clinic will be applied to Group 2. The clinical evaluation will be made on the 15th, 45th and 90th days; functional measurements will be taken.
The follow-up period was determined as 3 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline at 15th, 45th and 90th days in Pain
Time Frame: The clinical evaluation will be made on the 15th, 45th and 90th days
|
Visual analogue scale will be used for pain assessment in rest, activity and sleep.
The patient will be asked to define the severity of pain in a 10 cm line, from 0 to 10. 0 means no pain and 10 means unbearable pain.
|
The clinical evaluation will be made on the 15th, 45th and 90th days
|
|
Change from Baseline at 15th, 45th and 90th days in Range of Motion Assessment
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
range of motion of knee flexion and extension will be measured with digital inclinometer
|
The evaluation will be made on the 15th, 45th and 90th days
|
|
Change from Baseline at 15th, 45th and 90th days in Edema
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
edema will be made with measurement of the opposite extremity which will be compared with the tape measure
|
The evaluation will be made on the 15th, 45th and 90th days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline at 15th, 45th and 90th days in Complications
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
Complications such as superficial-deep skin infection or allergic reaction will be evaluated.
|
The evaluation will be made on the 15th, 45th and 90th days
|
|
Change from Baseline at 15th, 45th and 90th days in Functional Assessment of knee
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
Functional scores before and after surgery will be assessed with Knee Society Score.
The Knee Society Score (KSS) has two components (knee and function scores), each of which is scored separately from 0 to 100, with higher values indicating better outcomes.
|
The evaluation will be made on the 15th, 45th and 90th days
|
|
Change from Baseline at 15th, 45th and 90th days in Functional Assessment for osteoarthritis.
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
Functional scores before and after surgery will be assessed with Western Ontario and McMaster Universities Osteoarthritis Index Score.
The Western Ontario and McMaster University Osteoarthritis Index (WOMAC) is a disease-specific, self administered, health measure developed to study patients with osteoarthritis in the hip or knee.
The domains are pain, stiffness, physical function, social function and emotional function.
Every question can be given five alternative answers, which means a total of 0-4 points.
The maximum score in the Likert version is 20 points for pain, 8 for stiffness and 68 points for physical function.
A maximum score of 100 points occurred when the patient had minimum pain, stiffness and optimal function.
|
The evaluation will be made on the 15th, 45th and 90th days
|
|
Change from Baseline at 15th, 45th and 90th days in Thermographic measurement
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
Thermal changes in the skin will be assessed via a thermal camera at the knee region
|
The evaluation will be made on the 15th, 45th and 90th days
|
|
Change from Baseline at 15th, 45th and 90th days in Inflammatory markers as Interleukin 6 (IL-6)
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
Inflammatory markers in the blood such as Interleukin 6 (IL-6) will be assessed.
The reported values for IL-6 in the blood of healthy people vary between 0 and 43.5 pg/ml.
|
The evaluation will be made on the 15th, 45th and 90th days
|
|
Change from Baseline at 15th, 45th and 90th days in Inflammatory markers as Sedimentation rate
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
Inflammatory markers in the blood such as Sedimentation rate, the rate at which they settle is measured as the number of millimeters of clear plasma present at the top of the column after one hour (mm/hr), will be assessed.
|
The evaluation will be made on the 15th, 45th and 90th days
|
|
Change from Baseline at 15th, 45th and 90th days in Inflammatory markers as C-reactive protein (CRP)
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
Inflammatory markers in the blood such as C-reactive protein (CRP) will be assessed.
CRP concentration is measured in mg/L
|
The evaluation will be made on the 15th, 45th and 90th days
|
|
Change from Baseline at 15th, 45th and 90th days in Inflammatory markers as Creatine Kinase (CK)
Time Frame: The evaluation will be made on the 15th, 45th and 90th days
|
Inflammatory markers in the blood such as Creatine Kinase (CK) will be assessed.
Normal range is 22 to 198 U/L (units per liter)
|
The evaluation will be made on the 15th, 45th and 90th days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KA21/464
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
Emory UniversityVertex Pharmaceuticals IncorporatedNot yet recruitingKnee Osteoarthritis | Knee ArthritisUnited States
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
Clinical Trials on Sterile Kinesio Taping
-
Baskent UniversityCompletedEdema | Postoperative PainTurkey
-
University of BeykentRecruiting
-
Cardenal Herrera UniversityCompletedMobility Limitation | Myofascial Trigger Point Pain
-
Ataturk Training and Research HospitalUnknown
-
Istanbul Medipol University HospitalCompleted
-
Istinye UniversityCompleted
-
Cardenal Herrera UniversityCompletedMobility Limitation | Myofascial Trigger Point PainSpain
-
Norwegian School of Sport SciencesCompletedMuscle Weakness | Anterior Knee Pain | Knee SymptomsNorway
-
University of JazanCompletedMeniscus TearSaudi Arabia
-
Pamukkale UniversityNot yet recruitingTendon Injuries | Extensor Tendons of Finger AnomaliesTurkey (Türkiye)